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Edited by Laszlo NagyAbstract Adipocytes represent an important cellular source of
inﬂammatory mediators. However, the signals for the induction
of proinﬂammatory adipocyte activities are largely unknown.
Here, we demonstrate that heat shock protein (Hsp) 60, a potent
stimulator of innate immunity, induces the release of the inﬂam-
matory mediators interleukin-6, CXCL1 and monocyte chemoat-
tractant protein-1 in a time- and concentration-dependent
manner from cells of the adipocyte line 3T3-L1 and from adipo-
cytes of obese mice. These results identify Hsp60 as an important
regulator of adipocyte functions which contribute to the develop-
ment of inﬂammatory processes as observed in diabetes and dia-
betes-associated complications.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Adipose tissue, for a long time mainly characterized by its
fat storing capacity, has recently been recognized as the origin
of a variety of mediators with potent inﬂammatory eﬀects [1].
Meanwhile cells of the adipocyte fraction have been identiﬁed
as an important source of numerous inﬂammatory mediators
including interleukin-6 (IL-6), IL-8 and monocyte chemoat-
tractant protein-1 (MCP-1) [2,3]. Further studies now provide
increasing evidence that adipocyte-derived cytokines and che-
mokines sustain systemic low grade inﬂammation thereby pro-
moting the development of metabolic disorders, in particular
type 2 diabetes, and associated cardiovascular complications
[1,4]. More detailed investigations on the functional activities
of adipocytes revealed that this cell type shares many basic fea-
tures with innate immune cells, such as macrophages [5]. How-
ever, until now the physiological signals triggering the
formation of inﬂammatory mediators in adipocytes remain lar-
gely unknown.Abbreviations: Hsp60, heat shock protein 60; IL-6, interleukin-6; KC,
mouse chemokine CXCL1; MCP-1, monocyte chemoattractant pro-
tein-1; NZO, New Zealand obese; Pref-1, preadipocyte factor-1; LPS,
lipopolysaccharide
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doi:10.1016/j.febslet.2008.07.002Meanwhile it could be demonstrated that highly eﬃcient
stress signalling for macrophages, is provided by heat shock
protein (Hsp) 60 [6,7], a prominent member of the HSP family
[8], that exerts its stimulatory activity by speciﬁcally bound
bacterial lipopolysaccharide (LPS) [9]. Although these ﬁndings
in innate immune cells qualify Hsp60 as potential signal for the
induction of proinﬂammatory mediators from adipocytes, cur-
rently no data on the eﬀects of Hsp60 on adipocyte activities
are available.
Therefore, the aim of our study was to investigate the eﬀect
of Hsp60 on the induction of proinﬂammatory mediators in
adipocytes. By the use of the murine adipocyte line 3T3-L1
[10] and adipocytes of the New Zealand obese (NZO) mouse,
a model of human adiposity and the metabolic syndrome
[11], we could demonstrate for the ﬁrst time that adipocytes
are able to respond to Hsp60. Hsp60 dose-dependently in-
duced the release of IL-6, of KC (CXCL-1), the murine homo-
logue of human IL-8, and of MCP-1, indicating that
inﬂammatory adipocyte functions are under control of stress
proteins as potent endogenous danger signals.2. Materials and methods
2.1. Mice and 3T3-L1 cells
NZO mice were obtained from the breeding colony at the German
Diabetes Center. The mouse preadipocyte cell line 3T3-L1 was pur-
chased from ATCC, Manassas, VA, and was cultivated in DMEM
with 4.5 g/l glucose (PAA Laboratories GmbH, Co¨lbe, Germany)
supplemented with 10% (v/v) calf serum (PAA Laboratories GmbH),
antibiotic–antimycotic solution (Invitrogen GmbH, Karlsruhe,
Germany) and 1 mM Na-Pyruvat (PAA Laboratories GmbH) (culture
medium).
2.2. Isolation of murine adipocytes
Adipocytes were isolated from visceral adipose tissue of 6–9 months
old, normoglycemic, female NZO mice as described previously [12].
The resulting cells were cultivated and expanded in culture medium.
2.3. Determination of inﬂammatory mediators
3T3-L1 cells and primary preadipocytes (1 · 105/500 ll per well of a
48 well culture plate) were exposed to LPS (Escherichia coli O26:B6,
Sigma–Aldrich, Steinheim, Germany), to recombinant human Hsp60
(LPS contents 1.2 pg/lg protein) (Stressgen, Victoria, BC, Canada)
or to combinations of both reagents. After diﬀerent incubation periods
the concentrations of accumulated IL-6, KC and MCP-1 in the super-
natants were determined by ELISA (BD Biosciences, Heidelberg,
Germany; R&D Systems GmbH, Wiesbaden, Germany).2.4. Oil Red O staining
Oil Red O staining was performed according to a previously
described method [13].blished by Elsevier B.V. All rights reserved.
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To prove the purity of the primary adipocyte preparations and to ex-
clude macrophage-contaminations, the cells were stained with an allo-
phycocyanin-conjugated rat anti-mouse CD11b monoclonal antibody
(BD Biosciences). The macrophage line J774A.1 was used as positive
control for CD11b expression. The FITC-labelled rat anti-mouse prea-
dipocyte factor-1 (Pref-1) monoclonal antibody (MBL, Woburn, MA,
USA) was used to determine the adipocyte maturation state. Analyses
were performed with a FACSCalibur ﬂow cytometer (BD Biosciences).
2.6. Statistical analysis
Data were expressed as mean values + S.D. Statistical analysis was
performed using the Students t-test. Diﬀerences were considered statis-
tically signiﬁcant with P < 0.05.3. Results
3.1. Induction of the cytokine IL-6 in 3T3-L1 mouse
preadipocytes by LPS and Hsp60
The stress signals LPS and Hsp60 induce the release of IL-6
from 3T3-L1 cells (Fig. 1A). LPS caused a dose-dependent in-0
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Fig. 1. LPS- and Hsp60-induced IL-6 release from 3T3-L1 adipocytes. 3T3-L
concentrations of LPS (open bars) or Hsp60 (solid bars) for 24 h (A). For kin
for 0–72 h. IL-6 concentrations were determined by ELISA. Data show mean
corresponding medium control.
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Fig. 2. LPS- and Hsp60-induced KC formation from 3T3-L1 cells. 3T3-L1
concentrations of LSP (open bars) or Hsp60 (solid bars) for 24 h (A). For kin
for 0–48 h. KC concentrations were quantiﬁed by ELISA. Data show mean
corresponding medium control.crease of IL-6 concentrations up to 1.2 ± 0.1 ng/ml in the pres-
ence of 1000 ng/ml LPS (24 h). Exposure to rising Hsp60
concentrations resulted in an increase of IL-6 release up to
0.46 ± 0.04 ng/ml at 20 lg/ml Hsp60.
IL-6 accumulation induced by 10 and 1000 ng/ml LPS was
detectable already after 3 h and reached its maximum
(0.9–1.4 ng/ml) after 24–48 h (Fig. 1B). Exposure to Hsp60
for 3 h induced signiﬁcant IL-6 amounts (Fig. 1C) which re-
mained at an elevated level of about 0.2 ng/ml (10 lg/ml
Hsp60) or declined after a peak (0.5 ± 0.1 ng/ml) at 24 h
(20 lg/ml Hsp60).
3.2. Induction of the chemokines KC and MCP-1 in 3T3-L1
mouse preadipocytes by LPS and Hsp60
LPS- or Hsp60-exposure of 3T3-L1 cells dose-dependently
induced the release of KC up to 36.6 ± 1.0 ng/ml and 31.1 ±
2.2 ng/ml, respectively (Fig. 2A). KC levels rapidly increased
over the observation period and reached 44.9 ± 0.3 ng/ml in
LPS-exposed cells (Fig. 2B) and 41.5 ± 3.7 ng/ml in Hsp60-
treated cells (Fig. 2C).48 72
***
***
******
me (h)
/ml
/ml
/ml
0 6 24 48 72
0
0.25
0.50
0.75
1.00
** **
***
**
** *
* *
Time (h)
IL
-6
 (n
g/m
l)
C
Medium
Hsp60    1 µg/ml 
Hsp60  10 µg/ml 
Hsp60  20 µg/ml 
1 cells were incubated in the absence (medium) or presence of diﬀerent
etic studies the cells were exposed to LPS (B) or Hsp60 (C) as indicated
s ± S.D. of three determinations. **P < 0.01; ***P < 0.001 compared to
48 72
*
*** ***
******
ime (h)
ng/ml
ng/ml
ng/ml
0 6 24 48 72
0
25
50
75
***
***
***
***
***
***
**
***
***
**
Time (h)
K
C 
(n
g/m
l)
C
Medium
Hsp60    1 µg/ml 
Hsp60  10 µg/ml 
Hsp60  20 µg/ml 
cells were incubated in the absence (medium) or presence of diﬀerent
etic studies the cells were exposed to LPS (B) or Hsp60 (C) as indicated
s ± S.D. of three determinations. **P < 0.01; ***P < 0.001 compared to
E. Gu¨lden et al. / FEBS Letters 582 (2008) 2731–2736 2733A dose-dependent increase of MCP-1 concentrations up to
38.7 ± 0.1 ng/ml and 42.4 ± 5.0 ng/ml was observed in 3T3-
L1 cultures treated for 24 h with LPS and Hsp60, respectively
(Fig. 3A). MCP-1 levels increased to 36.2 ± 2.6 ng/ml in the
presence of 1000 ng/ml LPS (Fig. 3B) and to 64.6 ± 7.2 ng/ml
in the presence of 20 lg/ml Hsp60 (Fig. 3C).
3.3. Synergistic eﬀects of Hsp60 and LPS on the induction of
inﬂammatory mediators by 3T3-L1 mouse preadipocytes
To identify potential synergistic eﬀects of Hsp60 and LPS,
3T3-L1 cells were exposed to combinations of the reagents in
suboptimal stimulatory concentrations and after 24 h the levels
of IL-6, KC and MCP-1 (Fig. 4) were determined. The results
show that the stimulatory activity of combinations of Hsp60
and LPS is generally above the activity of the individual
agents, indicative for their additive eﬀect. Signiﬁcant synergis-
tic eﬀects on the production of IL-6 and KC were observed
when 10 lg/ml Hsp60 was combined with 1 or 3 ng/ml LPSA
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Fig. 3. LPS- and Hsp60-induced MCP-1 release by 3T3-L1 adipocytes. 3T3-L
concentrations of LPS (open bars) or Hsp60 (solid bars) for 24 h (A). For kin
for 0–48 h. MCP-1 concentrations were quantiﬁed by ELISA. Data show mea
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synergistic eﬀects on the induction of MCP-1 (Fig. 4C).
3.4. LPS and Hsp60 induce the release of inﬂammatory
mediators from adipocytes of NZO mice
To determine whether LPS and Hsp60 are also able to stim-
ulate the inﬂammatory activity of primary adipocytes, we ana-
lysed the responsiveness of adipocytes from NZO mice to these
stress signals.
FACS analysis of the isolated adipocyte population demon-
strated the lack of the macrophage speciﬁc marker CD11b in
>99% of the cells thereby proving the absence of contaminat-
ing macrophages. Staining with the fat speciﬁc dye Oil Red O
revealed a typical lipid droplet staining pattern in >99.2% of
the cells proving their adipocyte identity and further conﬁrm-
ing the purity of the adipocyte population. FACS-based detec-
tion of the adipocyte-speciﬁc maturation marker Pref-124 48
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(pre-)adipocytes.
Exposure of the cells to LPS or Hsp60 for 24 h resulted in a
dose-dependent release of IL-6, KC and MCP-1. Stimulation
with 10 ng/ml LPS was suﬃcient to induce maximum levels
of IL-6 (1.6 ± 0.1 ng/ml), KC (9.8 ± 0.1 ng/ml) and MCP-1
(47.0 ± 1.5 ng/ml) (Fig. 5A–C). After Hsp60 stimulation max-
imum release of IL-6 (1.1 ± 0.2 ng/ml) (Fig. 5A) and MCP-1
(39.5 ± 0.1 ng/ml) (Fig. 5C) was observed at a concentration
of 20 lg/ml of the stress protein, whereas the induction of max-
imum KC levels (9.4 ± 0.1 ng/ml) was already reached at an
Hsp60 concentration of 10 lg/ml (Fig. 5B). Interestingly, both
LPS and Hsp60 failed to induce the release of TNF-a from
3T3-L1 cells and NZO-derived adipocytes.4. Discussion
Adipocytes have been recognized as integral components of
the complex network of tightly interacting metabolic and
immunological processes [1]. In view of their central role in
obesity and related diseases, adipocyte activities involved in
metabolic control have long been in the focus of interest,
whereas at present only limited information is available on adi-
pocyte functions relevant for the control of immunological
processes. Although recent ﬁndings demonstrate a strong
immunomodulatory potential of members of the HSP family
[6,14], the possible eﬀects of Hsp on adipocyte functions are
unknown.
In this study, we now examined the eﬀect of Hsp60, a prom-
inent member of the HSP family and a highly potent endoge-
nous stress signal, on the induction of inﬂammatory mediators
from mouse preadipocytes. For our experiments, the adipo-
cytes were exposed to Hsp60 concentrations covering a range
from physiological serum levels in rodents (below 10 lg/ml)
up to a concentration of 20 lg/ml, reﬂecting the elevated
Hsp60 serum levels found under pathological conditions
[15,16]. The studies were performed with cells of the adipocyte
line 3T3-L1 complemented by investigations on primary adi-
pocytes isolated from the visceral fat depot of the NZO mouse
[11]. Control experiments conﬁrmed the purity of the NZO
mouse-derived adipocyte population and excluded the pres-ence of contaminating cells, particularly macrophages which
possess functional properties similar to adipocytes [5] and ex-
hibit pronounced responsiveness to Hsp60 [7]. Both, 3T3-L1
cells and NZO mouse adipocytes showed signiﬁcantly in-
creased release of the cytokine IL-6 and of the chemokines
KC and MCP-1 in response to LPS, thus conﬁrming the high
adipocyte-stimulating capacity of this microbial stress signal
[3].
In comparative approaches, we were able to demonstrate for
the ﬁrst time that Hsp60 induces the release of the inﬂamma-
tory mediators IL-6, KC and MCP-1 from 3T3-L1 cells as well
as from primary NZO mouse-derived adipocytes. In both cell
types the Hsp60-induced release of the mediators was strictly
dose dependent. Both cell types showed a strict dose-depen-
dence of the Hsp60-induced release of inﬂammatory media-
tors.
In an attempt to mimick inﬂammatory conditions generally
characterized by the simultaneous appearance of diﬀerent,
potentially synergizing stress signals [17], we exposed 3T3L-1
cells to combinations of Hsp60 and LPS. Concurring with
our previous ﬁndings on murine macrophages we observed
additive stimulatory eﬀects when Hsp60 was acting on 3T3-
L1 cells in combination with LPS [9]. Treatment of the cells
with mixtures of the agents at suboptimal stimulatory concen-
trations resulted in diﬀerential stimulatory eﬀects dependent
on the Hsp60-LPS ratio acting on the cells. The observed dif-
ferential eﬀects of the Hsp60-LPS combinations on the induc-
tion of the investigated inﬂammatory mediators most likely
reﬂect the speciﬁc and highly complex interactions between
the two stress signals that mutually aﬀect their stimulatory
capacities [9].
The striking similarity in the reactivity of cells of the adipo-
cyte line and of the primary mouse adipocytes indicates that
Hsp60 responsiveness represents a basic property of murine
pre-adipocytes. The failure of Hsp60 to induce the release of
TNF-a concurs with previous ﬁndings [3] and implicates that
Hsp60-exposure does not cause a general, unspeciﬁc stimula-
tion of adipocyte secretory activity but leads to the activation
of selected pathways resulting in the formation of a distinct
pattern of mediators. Our ﬁndings further implicate the pres-
ence of a yet undeﬁned Hsp60 receptor on adipocytes. Since
adipocytes in many instances resemble innate immune cells
E. Gu¨lden et al. / FEBS Letters 582 (2008) 2731–2736 2735[5], it might be speculated that the Hsp60 receptor on adipo-
cytes shares basic features with the Hsp60 receptor on macro-
phages, a dominant population of antigen-presenting cells. The
results of our previous studies on Hsp60-macrophage interac-
tions suggest that the Hsp60 receptor complex comprises sev-
eral functional components including the toll-like receptor 4
(TLR-4) as an indispensable structure for the mediation of
the stimulatory Hsp60 eﬀects [18,19]. The recent identiﬁcation
of functionally active TLR4 on adipocytes [20] implicates a
role of this transmembrane protein also in Hsp60–adipocyte
interactions.
Although mature adipocytes constitute by far the largest cell
population of adipose tissue our present study focuses on pre-
adipocytes since their functional activities largely resemble
those of immunocompetent cells of the innate immune system
[5]. Pre-adipocytes show phagocytic and microbicide activity
and, when compared to mature adipocytes, they exhibit a
strongly increased responsiveness to stress signals of microbial
origin [21].
Our observations with cultivated adipocytes could be of rel-
evance for the understanding of the inﬂammatory processes
associated with the development of metabolic disorders includ-
ing obesity, diabetes and cardiovascular complications. It
might be speculated that the systemically increased Hsp60 lev-
els observed in these disease states [22,23] cause (chronic) adi-
pocyte-stimulation. Another origin of adipocyte stimulating
Hsp60 might be the adipose tissue itself, which is known to
be a source of inﬂammatory activities [24] that could result
in the local accumulation of stress signals. On the other hand,
it is conceivable to assume that the Hsp60-induced release of
inﬂammatory adipocyte mediators promotes the attraction
and activation of immune cells in the adipose tissue [25] and
contributes to the systemic elevation of pro-inﬂammatory
mediators described in individuals with impaired glucose
metabolism [26]. In the context of our present ﬁndings in mur-
ine adipocytes these considerations warrant further investiga-
tions with human adipocytes preferably isolated from the
visceral fat depot, which is regarded as a major source of
inﬂammatory mediators contributing to the pathogenesis of
metabolic disorders and associated complications [27].
Taken together, this study demonstrates that adipocytes are
able to respond to the endogenous danger signal Hsp60 by the
release of inﬂammatory mediators, thereby sharing a basic fea-
ture with innate immune cells. Our ﬁndings implicate an
important role of Hsp60 in the control of adipocyte activities
that may contribute to the development of diabetes-associated
inﬂammatory processes.
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